ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 680

$1.02M Total Retail Price of All Prescriptions

Rank: 76 out of 680

828 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 828 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 828 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 847 758 1 1
LEVOTHYROXINE SODIUM 609 550 2 2
OMEPRAZOLE 531 446 3 7
LISINOPRIL 479 412 4 5
SIMVASTATIN 455 355 5 3
METFORMIN HCL ER 451 378 6 54
HYDROCODONE-ACETAMINOPHEN 438 287 S3 7 4
PRAVASTATIN SODIUM 407 356 8 10
TRAMADOL HCL 400 314 9 18
ALPRAZOLAM 376 313 10 72
METFORMIN HCL 367 304 11 8
LOVASTATIN 358 325 12 44
LOSARTAN POTASSIUM 343 300 13 21
ZOLPIDEM TARTRATE 299 256 14 17
GLIMEPIRIDE 288 262 15 29
CITALOPRAM HBR 284 262 16 22
GABAPENTIN 237 168 17 15
AMLODIPINE BESYLATE-BENAZEPRIL 226 184 18 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 224 176 19 37
INSULIN SYRINGE 221 170 20 86
LOSARTAN-HYDROCHLOROTHIAZIDE 214 176 21 51
TAMSULOSIN HCL 213 187 22 34
ATORVASTATIN CALCIUM 194 157 23 11
METOPROLOL TARTRATE 188 163 24 12
FENOFIBRATE 185 158 25 66
FUROSEMIDE 182 151 26 6
HYDROCHLOROTHIAZIDE 172 127 27 9
ATENOLOL 169 130 28 19
ALENDRONATE SODIUM 164 160 29 32
BISOPROLOL-HYDROCHLOROTHIAZIDE 163 140 30 156
DIOVAN 161 147 31 31
PANTOPRAZOLE SODIUM 152 128 32 30
FLUTICASONE PROPIONATE 152 134 32 41
AZITHROMYCIN 149 119 34 42
ALLOPURINOL 146 120 35 33
NEXIUM 145 108 36 16
LANTUS 143 116 37 49
JANUVIA 132 113 38 60
GEMFIBROZIL 130 99 39 106
TEMAZEPAM 129 122 40 155
TRAZODONE HCL 128 92 41 48
POTASSIUM CHLORIDE 125 104 42 14
FINASTERIDE 124 112 43 109
ONGLYZA 123 120 44 136
DONEPEZIL HCL 123 117 44 27
ENALAPRIL MALEATE 116 113 46 65
MELOXICAM 116 90 46 24
LORAZEPAM 108 103 48 125
IBUPROFEN 106 90 49 126
ENABLEX 104 85 50 217
GLYBURIDE-METFORMIN HCL 100 55 R 51 107
METOPROLOL SUCCINATE 99 92 52 13
NAMENDA 92 92 53 35
NAPROXEN 92 62 53 121
POLYETHYLENE GLYCOL 3350 89 78 55 62
BISOPROLOL FUMARATE 86 62 56 173
ADVAIR DISKUS 84 69 57 53
DIOVAN HCT 83 58 58 55
IRBESARTAN 82 66 59 247
DIAZEPAM 77 39 60 188
TRADJENTA 72 62 61 301
CLOTRIMAZOLE-BETAMETHASONE 71 53 62 138
PAROXETINE HCL 71 63 62 76
CARVEDILOL 70 70 64 23
NIFEDICAL XL 69 55 65 220
BUTALBITAL-ACETAMINOPHEN-CAFFE 67 48 R 66 346
IRBESARTAN-HYDROCHLOROTHIAZIDE 66 57 67 379
SYNTHROID 66 54 67 38
VIAGRA 64 52 69 214
TIZANIDINE HCL 62 28 70 140
NOVOLOG MIX 70-30 60 48 71 290
PLAVIX 58 49 72 39
LYRICA 57 37 73 77
EVISTA 57 57 73 135
CLOPIDOGREL 56 48 75 26
PREDNISONE 54 46 76 50
CLONIDINE HCL 54 49 76 36
WARFARIN SODIUM 53 45 78 20
GLIPIZIDE XL 52 48 79 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.